StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19−0.00 (-1.01%)

Close on Nov 18, 2026Market cap $2.37MP/E –Yield –

20/20 Biolabs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

20/20 Biolabs's price to sales ratio was 1.3× on Nov 11, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×–

More 20/20 Biolabs figures

See a number that looks wrong?